相似文献
1
Influences on the Hematopoietic Stem Cell Niche.对造血干细胞微环境的影响。
SciBase Hematol Blood Disord. 2024;1(1). Epub 2024 Sep 6.
2
The Bone Marrow Microenvironment in Health and Myeloid Malignancy.骨髓微环境与髓系恶性肿瘤。
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):a031328. doi: 10.1101/cshperspect.a031328.
3
Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.骨髓微环境中的种系突变与造血失调。
Exp Hematol. 2018 Oct;66:17-26. doi: 10.1016/j.exphem.2018.07.001. Epub 2018 Aug 1.
4
Where Hematopoietic Stem Cells Live: The Bone Marrow Niche.造血干细胞的栖息地：骨髓龛。
Antioxid Redox Signal. 2018 Jul 10;29(2):191-204. doi: 10.1089/ars.2017.7419. Epub 2018 Jan 9.
5
Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation.稳态、恶性肿瘤及骨髓移植过程中的造血干细胞微环境
Front Cell Dev Biol. 2021 Jan 22;9:621214. doi: 10.3389/fcell.2021.621214. eCollection 2021.
6
The hematopoietic stem-cell niche in health and leukemia.健康与白血病状态下的造血干细胞微环境
Cell Mol Life Sci. 2017 Feb;74(4):579-590. doi: 10.1007/s00018-016-2306-y. Epub 2016 Jul 19.
7
Cellular Niches for Hematopoietic Stem Cells and Lympho-Hematopoiesis in Bone Marrow During Homeostasis and Blood Cancers.骨髓中造血干细胞和淋系造血细胞的细胞龛在稳态和血液癌症中的作用。
Curr Top Microbiol Immunol. 2021;434:33-54. doi: 10.1007/978-3-030-86016-5_2.
8
The hematopoietic stem cell niche: What's so special about bone?造血干细胞龛：骨骼有何特别之处？
Bone. 2019 Feb;119:8-12. doi: 10.1016/j.bone.2018.05.017. Epub 2018 May 17.
9
[Niches of Hematopoietic Stem Cells in Bone Marrow].[骨髓中造血干细胞的生态位]
Mol Biol (Mosk). 2019 Nov-Dec;53(6):1012-1019. doi: 10.1134/S0026898419060028.
10
Normal and leukemic stem cell niches: insights and therapeutic opportunities.正常和白血病干细胞龛：见解与治疗机会。
Cell Stem Cell. 2015 Mar 5;16(3):254-67. doi: 10.1016/j.stem.2015.02.014.
本文引用的文献
1
Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia.肥胖促进急性髓系白血病中神经酰胺介导的NADPH氧化酶的作用。
J Blood Disord Malig. 2024;2(1). Epub 2024 Apr 15.
2
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia.神经酰胺纳米脂质体增强 venetoclax 和阿糖胞苷在急性髓系白血病模型中的疗效。
FASEB J. 2022 Oct;36(10):e22514. doi: 10.1096/fj.202200765R.
3
Ceramide: improving Bcl-2 inhibitor therapy.神经酰胺：改善Bcl-2抑制剂疗法。
Blood. 2022 Jun 30;139(26):3676-3678. doi: 10.1182/blood.2022016608.
4
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.利用神经酰胺的力量：急性髓系白血病的前景。
Blood Rev. 2022 Sep;55:100950. doi: 10.1016/j.blre.2022.100950. Epub 2022 Apr 9.
5
Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.神经酰胺诱导的综合应激反应克服了急性髓系白血病中 Bcl-2 抑制剂耐药性。
Blood. 2022 Jun 30;139(26):3737-3751. doi: 10.1182/blood.2021013277.
6
Leptin-mediated proinflammatory bone marrow environment in acquired aplastic anemia.瘦素介导的获得性再生障碍性贫血中的促炎骨髓微环境。
Cytokine. 2022 Apr;152:155829. doi: 10.1016/j.cyto.2022.155829. Epub 2022 Feb 23.
7
BCL2 and MCL1 inhibitors for hematologic malignancies.BCL2 和 MCL1 抑制剂治疗血液系统恶性肿瘤。
Blood. 2021 Sep 30;138(13):1120-1136. doi: 10.1182/blood.2020006785.
8
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.骨髓基质细胞来自 MDS 和 AML 患者，表现出增加的成脂潜能，Delta-like-1 表达降低。
Sci Rep. 2021 Mar 15;11(1):5944. doi: 10.1038/s41598-021-85122-8.
9
Sphingolipids as Regulators of Neuro-Inflammation and NADPH Oxidase 2.鞘脂类作为神经炎症和 NADPH 氧化酶 2 的调节剂。
Neuromolecular Med. 2021 Mar;23(1):25-46. doi: 10.1007/s12017-021-08646-2. Epub 2021 Feb 5.
10
Leukemia cells remodel marrow adipocytes via TRPV4-dependent lipolysis.白血病细胞通过 TRPV4 依赖性脂解重塑骨髓脂肪细胞。
Haematologica. 2020 Nov 1;105(11):2572-2583. doi: 10.3324/haematol.2019.225763.
Zotero 插件